Rheumatoid arthritis is an autoimmune disease characterized by T-cell infiltration of the synovium of joints. Analysis of the phenotype and antigen specificity of the infiltrating cells may thus provide insight into the pathogenesis of rheumatoid arthritis. T cells were cloned with interleukin 2, a procedure that selects for in vivo-activated cells. All clones had the CD4 CDW29 phenotype. Their antigen specificity was tested by using a panel of candidate joint autoantigens. Four of 17 reacted against autologous blood mononuclear cells. Two clones proliferated in response to collagen type II. After 21 months, another set of clones was derived from synovial tissue of the same joint. One of eight clones tested showed a strong proliferative response against collagen type II. The uncloned synovial T cells of a third operation from another joint also responded to collagen type II. The persistence of collagen type II-specific T cells in active rheumatoid joints over a period of 3 years suggests that collagen type II could be one of the autoantigens involved in perpetuating the inflammatory process in rheumatoid arthritis.
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Rheumatoid arthritis is a chronic inflammatory disease of synovial joints leading to destruction of cartilage and erosion of bone (1) . Currently, the mechanisms underlying the perpetuation of the chronic inflammation and the consequent tissue damage are poorly understood. It is widely considered that the immune system is a major participant in these processes, perhaps through the activation of complement by immune complexes containing rheumatoid factor (2) or by activated immunocompetent cells (3) releasing protein mediators such as interleukin 1 (IL-1), tumor necrosis factor, and interferon-y.
Study of cell-surface markers and cellular organization has shown that there is a predominance of T lymphocytes in the synovial infiltrate (4), with many T cells showing unequivocal markers of activation such as receptors for IL-2 and HLA class II molecules (5) . The HLA class II-bearing tissue cells are intimately related to T cells, permitting the cell interactions for activation to occur (6) . These features are shared with other autoimmune diseases and suggest that chronic stimulation of T helper cells by class II-bearing antigenpresenting cells may be one of the major steps involved in disease chronicity (3) . It seemed logical therefore to investigate the pathogenesis of rheumatoid arthritis by phenotypic analysis of the infiltrating T cells and by cloning the activated infiltrating T cells by a procedure that we have used successfully in studying other autoimmune diseases (7) .
Here we report the cloning of the activated T cells from a patient with active erosive rheumatoid arthritis. In two operative samples, 21 months apart, collagen type II-specific clones were detected at a frequency of -'12%. In a third sample, the uncloned joint T cells also responded to collagen type II. This persistent response suggests a possible role of these T cells in maintaining the chronic inflammatory state in rheumatoid arthritis, since in these joints there is abundant HLA class II and collagen type II available to restimulate the T cells.
MATERIALS AND METHODS
Patient. C.L., a Caucasian female (HLA DR-1,-6), developed polyarthritis diagnosed as rheumatoid arthritis in 1975. Laboratory investigations have shown a consistent lack of IgM rheumatoid factor. There was a low titer of anti-nuclear antibody with activity against DNA-histone and singlestranded DNA. She was treated with gold salts. After 4 years, she relapsed with severe symptoms. A right knee synovectomy was performed, which was the source of the first cloning procedure; 21 months later, because of severe pain, cartilage damage, and loss of mobility, a knee prosthesis was inserted, providing the source of synovium for the second cloning experiments. A third operation, to insert a prosthesis into the other knee was performed a year later.
Heparinized peripheral blood (50 ml) was obtained the day before surgical treatment and again after surgery. Peripheral blood mononuclear cells (PBM) were purified by Ficoll gradient. Synovial membrane was prepared by digestion with collagenase type IV (5 mg/ml) (Cooper Biomedical) and DNase (0.15 mg/ml) (Sigma) at 37°C (8) . Some of the cells were cryopreserved and other cells were layered over a Ficoll gradient to purify the mononuclear cells.
Culture. Mononuclear cells purified as described above from the synovial membrane were cultured with purified human recombinant IL-2 (20 ng/ml) (IL-2, Ajinomoto, Kawasaki, Japan) in RPMI 1640 medium supplemented with antibiotics and 10% AB human serum (complete medium) and cloned by a procedure that selects for T cells activated in vivo (8) . Briefly, after 1 week of culture with IL-2, the cells were purified over a Ficoll gradient and cloned by limiting dilution (0.3 cell per well) in Terasaki plates, with irradiated (4000 rad; 1 rad = 0.01 Gy) autologous PBM (105 cells per ml), IL-2 (20 ng/ml), and the monoclonal antibody OKT3 (30 ng/ml). The expanding clones were transferred every week in fresh complete medium supplemented with IL-2 (20 ng/ml), OKT3 (30 ng/ml), and irradiated (4000 rad) autologous PBM.
Antigens. Collagen type II was prepared as described (9 Assays. The proliferative assay was performed with 104 cloned T cells in the presence of 2 x 104 irradiated (4000 rad) autologous PBM as a source of antigen-presenting cells and different antigenic preparations at various concentrations (1-100 gg/ml) in 200 ,ul of complete medium in a 96-microwell plate for 72 hr (8) . Wells were pulsed with 1 puCi of [3H]thymidine (1 Ci = 37 GBq) (Amersham) 10 hr before they were harvested onto glass fiber filter paper with a semiautomated cell harvester (Flow Laboratories, Titertek 550). The strips were then assayed in a liquid scintillation spectrometer Anti-Collagen Antibody Assay. Collagen types I-V were diluted to 1 ,ug/ml in 0.05 M bicarbonate buffer (pH 9.6) and 100 ,ul was added to each well of a 96-well Titertek PVC immunoassay plate (Flow Laboratories). The diluted collagen solutions were denatured by heating to 50°C for 15 min and then allowed to cool before coating plates at room temperature for 2 hr; then they were washed three times with phosphate-buffered saline (PBS)/0.1% Tween 20. Doubling dilutions in PBS/Tween were performed on the plates, which were incubated at room temperature for 2 hr before washing three times with PBS/Tween. An alkaline phosphataseconjugated anti-human IgG (Sigma) was diluted 1:1000 and incubated for 1 hr. After exhaustive washing in PBS/Tween the substrate p-nitrophenyl phosphate (1 mg/ml) in 0.05 M bicarbonate buffer (pH 9.6) was added. After color development, the plate was read on an ELISA plate reader at 405 nm.
RESULTS
Antigen Specificity of Rheumatoid Arthritis T-Cell Clones.
In principle, almost any joint constituent could be the relevant autoantigen(s). To maximize the possibility of detecting relevant antigens, T-cell clones were screened with autologous irradiated PBM as antigen-presenting cells and a panel of candidate antigens: rheumatoid factor, human IgG, human collagen types I and II, human cartilage matrix protein, and proteoglycan preparations. Based on results from other groups, mycobacterial antigen (14) and an Epstein-Barr virus-derived peptide (15) were also used. Of 17 clones tested initially, 11 did not show any reactivity in a 3-day proliferation assay, and 4 reacted against autologous PBM, demonstrating the so-called "autologous mixed lymphocyte reaction" (AMLR). Fig. 1 shows the data from one In all experiments, these were <10%. ND, not done; PBL, peripheral blood lymphocytes; MTSE, mycobacterium tuberculosis soluble extract; P.G., proteoglycan.
of the AMLR clones. One clone reacted specifically to collagen type II preparation ( Fig. 2A) , and another clone reacted against autologous peripheral blood lymphocytes but its proliferative response was significantly increased when collagen type II was introduced as antigen (Fig. 2B ). These clones were tested on three or four occasions for their specificity, and similar results were obtained in all experiments.
From the second surgical specimen, the reactivity of eight T-cell clones has been assayed. None reacted against autologous blood mononuclear cells. One of these showed a strong response to collagen type II (Fig. 2C) . From the third surgical specimen, the uncloned joint cells were assayed directly with antigen and a response to collagen type II was noted (Fig. 3) .
Immunophenotyping the T-Cell Clones. Of the panel of clones (n = 65) derived from the first operative sample, a random selection of 20 was expanded and phenotyped by using the panel of monoclonal antibodies. All were CD3+CD4+ and 4B4+. ( Fig. 4) directed against the products of the V,95 gene family (16) . Clones obtained from the second operative specimen have also been phenotyped and were all of the CD3+CD4+ phenotype (data not shown). Antibody Response to Collagen Type II. The results revealed strong reactivity with native type II collagen (Fig. 5A ) and somewhat less against denatured type II (Fig. 5B) . Negligible reactivity was observed against any of the other collagen types tested.
DISCUSSION
We have generated and expanded T-cell clones derived from the activated T cells present in the two synovial membrane preparations of a single patient with active erosive RA to study in detail the infiltrating T lymphocytes. All Antigens were used at 100 ,g/ml, except MTSE was at 1 kig/ml. These were the optimal concentrations. phenotyped were CD3+CD4+ CDW29', which is probably due to the presence in the synovium of this patient of activated T lymphocytes chiefly in the CD4' CDW29' population and to an almost complete lack of CD4' CD45R' cells (data not shown), as reported previously (17) .
The lack of CD8 clones was not due to the incapacity of this cloning method, as CD8 clones have been obtained with this method from other rheumatoid arthritis joints (unpublished data) and in Hashimoto's thyroiditis (8) In rheumatoid arthritis, a number of autoantibodies have been well characterized (18 (20) .
However, the most interesting result obtained in the analysis of the specificity of the clones is the reactivity against collagen type II found in 2 clones of 25 tested, a relatively high frequency for T cells not selected by antigen. A third clone that proliferated against autologous PBM, showed a 2-fold increased response when collagen type II was present. A similar phenomenon, of dual recognition of autologous class II, enhanced by addition of antigen, has been observed in a murine model (21) . The frequency of autoantigen reactive T cell in these samples is high (-12%). This is comparable to the frequency of thyrocyte-specific T-cell clones derived from the lymphocytic infiltrate in Graves disease operative specimens that we reported initially (7) (22) , including this one, with evidence for local production in joints (23) . Serum taken at the time of the first operative sample was strongly reactive by ELISA against native collagen type II, less against denatured collagen type II, but not against collagen types I, III, IV, and V (Fig. 4) . This indicates a strong specific immune response against collagen type II in this individual. Second, it is possible to induce with collagen type II in experimental animals (guinea pigs, rats, mice) a genetically determined chronic arthritis that resembles rheumatoid arthritis (22) . Not all rheumatoid patients produce anti-collagen type II antibodies (22 of collagen type II-specific clones than other patients. Recently, it has been reported that rhesus and cynomolgus monkeys immunized with bovine collagen type II develop a chronic polyarthritis (24) .
The purity of the collagen type II preparation used (9) excludes the possibility that other cartilage-speciflic collagens such as type IX, X, or XI may be recognized by these clones. Of interest would be to determine which part of the collagen type II molecule is recognized and whether all clones recognize a single epitope. We have not yet investigated whether the minor cartilage-specific collagens are recognized by any of these clones.
We have analyzed the lymphokines released by these clones and have found that the majority can release a high level of interferon--y (25). Of particular interest was the finding that these T cells, including the collagen-specific clones can also produce tumor necrosis factors a and (lymphotoxin) (25) , molecules that can induce cartilage degradation (26) . Moreover, there is evidence that these lymphokines (interferon-y and tumor necrosis factor) may synergize in the induction of HLA class II (27) and in the production of other cytokines such as IL-1 (unpublished data), which have been found in high levels in the synovial fluid of rheumatoid arthritis patients (28) . 
